Viral Thymidine Kinase in Positive-Negative Selection: GATE BT Solved

Viral thymidine kinase (TK) serves as the key enzyme in positive-negative selection for transformed animal cells, where its expression leads to cell death upon ganciclovir exposure. This mechanism, commonly tested in exams like GATE Biotechnology, relies on TK’s ability to phosphorylate ganciclovir into a toxic form. The correct answer is (B) viral thymidine kinase.​

Option Analysis

Positive-negative selection enriches cells with desired integrations by first selecting for a positive marker (e.g., antibiotic resistance) and then eliminating unwanted ones using a negative marker like viral TK.​

• (A) Pyruvate kinase: This glycolytic enzyme converts phosphoenolpyruvate to pyruvate and ATP, playing no role in nucleoside analog metabolism or ganciclovir sensitivity. Cells expressing it survive ganciclovir, as it lacks phosphorylation activity for the drug.​

• (B) Viral thymidine kinase: Correct. HSV-1 TK phosphorylates ganciclovir to ganciclovir-monophosphate, which cellular kinases further convert to triphosphate—a DNA chain terminator killing TK-expressing cells. Non-expressing cells survive, enabling counterselection.​

• (C) Viral serine/threonine kinase: These phosphorylate proteins on Ser/Thr residues, not nucleosides, so they do not activate ganciclovir. No cell death occurs in its presence.​

• (D) Viral tyrosine kinase: Targets Tyr residues on proteins for signaling, unrelated to ganciclovir activation or selection processes.​

Introduction to Viral Thymidine Kinase Positive-Negative Selection

Viral thymidine kinase positive-negative selection is a cornerstone technique in molecular biology for gene targeting in animal cells. Transformed cells expressing viral thymidine kinase are selectively killed by ganciclovir, allowing precise enrichment of desired clones. This method, featured in competitive exams like GATE Biotechnology, combines positive selection (e.g., via neoR) with negative selection using TK-ganciclovir suicide.​

How Ganciclovir Kills TK-Expressing Cells

Ganciclovir, a nucleoside analog, remains inert in normal cells lacking viral TK. In TK-positive cells, viral thymidine kinase (from HSV-1) phosphorylates it to monophosphate, followed by cellular GMP kinase to di- and triphosphate forms. The triphosphate inhibits DNA polymerase and terminates chains, inducing apoptosis—ideal for eliminating non-homologous recombinants.​

Key steps:

• Expression of HSV-TK in transfected cells.

• Ganciclovir addition triggers phosphorylation cascade.

• TK+ cells die; TK- cells (with correct integration) survive.

Applications in Gene Targeting

This system excels in knock-in/knock-out via homologous recombination. Vectors carry positive markers for initial survival and TK for counterselection. Used in embryonic stem cells and cancer gene therapy, it achieves >90% targeting efficiency.​

Exam Relevance for GATE Biotechnology

GATE 2020 BT Q9 tested this exact concept. Aspirants from Jaipur preparing IIT JAM/GATE often encounter it in molecular biology sections. Master it alongside HSV-TK/ganciclovir/gancyclovir variants for scoring.​